Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06792474 · ClinicalTrials.gov registry record · Phase 4
Influence of Lidocaine Infusion on Motor Evoked Potential Thresholds
A Phase 4 study, sponsored by Dartmouth-Hitchcock Medical Center.
- Not yet
- Registry status
- Phase 4
- Development phase
- 44
- Enrollment target
NCT06792474 is a Phase 4 study that has not yet begun recruiting, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 44 participants.
The verdict
NCT06792474, a Phase 4 study, has not yet begun recruiting, sponsored by Dartmouth-Hitchcock Medical Center.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 44 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of lidocaine infusion on intraoperative neuromonitoring in patients undergoing spine surgery.
Interventions
- DRUG Normal saline
- DRUG Lidocaine in Saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2026-08 |
| Est. Completion | 2027-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06792474
The ClinicalTrials.gov registry entry for NCT06792474 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal saline is the first listed.
NCT06792474 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06792474 about?
NCT06792474 is a clinical study titled "Influence of Lidocaine Infusion on Motor Evoked Potential Thresholds". The purpose of this study is to determine the effect of lidocaine infusion on intraoperative neuromonitoring in patients undergoing spine surgery.
What is the current status of trial NCT06792474?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 44 participants. The study started on 2026-08. Estimated completion is 2027-08.
What interventions are being tested in trial NCT06792474?
The interventions under investigation include: Normal saline (DRUG), Lidocaine in Saline (DRUG).
Who is sponsoring clinical trial NCT06792474?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.